Why Non-invasive Prenatal Testing (NIPT)?
Generation is non-invasive prenatal testing (NIPT) that screens for chromosomal changes that can affect your baby's future health.
NIPT uses a blood sample from the mother to determine the chance of a chromosomal condition in the developing baby from as early as the 10th week of pregnancy. Generation is highly accurate and safe, and may help avoid more invasive prenatal testing by amniocentesis and chorionic villus sampling.
Three NIPT options are available: Generation, Generation 46 and Generation Plus. All options provide information on the chance that your baby is affected by common chromosomal conditions including Down syndrome. Your doctor can advise on the best Generation test for your personal circumstances.
Introducing the Generation screen
- You can have an NIPT blood test as early as 10 weeks.
- NIPT is the most accurate prenatal screening test available for Trisomy 21, 18 & 13.
- All screens are analysed in an accredited laboratory. Generation and Generation 46 are performed in our accredited Australian laboratory. If a Generation Plus test is requested, your sample will be sent to an accredited laboratory in California.
- The lowest reported test failure rate of any NIPT.
- Doctors will receive results within 3 - 7 business days of sample arriving at the Genomic Diagnostics laboratory for Generation and Generation 46, and 11 - 15 business days of sample arriving at the overseas laboratory for Generation Plus.
- Only a single tube of blood is drawn.